Does bacterial infection cause genome instability and cancer in the host cell?

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 761, Issue , 2014, Pages 1-14

  Kovalchuk, Olga ^a   Walz, Paul ^a   Kovalchuk, Igor ^a  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Bacterial infection; Bystander effect; Cancer; Cell proliferation; Genome stability; Lipopolysaccharides

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYCLIN DEPENDENT KINASE; CYCLOOXYGENASE 2; CYTOTOXIC NECROTIZING FACTOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR; ESCHERICHIA COLI ENDOTOXIN; FOCAL ADHESION KINASE 1; NITRIC OXIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANGIOGENESIS; ANTIGEN RECOGNITION; APOPTOSIS; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BORRELIA; BORRELIA VINCENTII; CAMPYLOBACTER JEJUNI; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; CHRONIC INFLAMMATION; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL TUMOR; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA DAMAGE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; FUSOBACTERIUM; GALLBLADDER CANCER; GENOMIC INSTABILITY; HELICOBACTER PYLORI; HORIZONTAL GENE TRANSFER; HOST CELL; HUMAN; HYPERPLASIA; IMMUNE RESPONSE; IMMUNOPROLIFERATIVE SMALL INTESTINAL DISEASE; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOMA; MICROBIAL MORPHOLOGY; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; SALMONELLA TYPHIMURIUM; SQUAMOUS CELL CARCINOMA; STREPTOCOCCUS BOVIS; TROPHERYMA WHIPPELII; VIBRIO CHOLERAE; VIRUS INFECTION;

BACTERIA (MICROORGANISMS);

BACTERIAL INFECTION; BYSTANDER EFFECT; CANCER; CELL PROLIFERATION; GENOME STABILITY; LIPOPOLYSACCHARIDES;

ANIMALS; BACTERIAL INFECTIONS; GENOMIC INSTABILITY; HUMANS; NEOPLASMS;

EID: 84895863739     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2014.01.004     Document Type: Review

References (142)

1. Kuper H., Adami H.O., Trichopoulos D. Infections as a major preventable cause of human cancer. Journal of Internal Medicine 2000, 248:171-183.
2. Lax A.J., Thomas W. How bacteria could cause cancer: one step at a time. Trends in Microbiology 2002, 10:293-299.
3. Onuigbo W.I. Some nineteenth century ideas on links between tuberculous and cancerous diseases of the lung. British Journal of Diseases of the Chest 1975, 69:207-210.
4. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
5. Rous P. A transmissible avian neoplasm. (Sarcoma of the common fowl.). Journal of Experimental Medicine 1910, 12:696-705.
6. Rous P., Kidd J.G. A comparison of virus-induced rabbit tumors with the tumors of unknown cause elicited by tarring. Journal of Experimental Medicine 1939, 69:399-424.
7. Hsieh Y.H., Hsu J.L., Su I.J., Huang W. Genomic instability caused by hepatitis B virus: into the hepatoma inferno. Frontiers in Bioscience: A Journal and Virtual Library 2011, 16:2586-2597.
8. Vilkin A., Niv Y. Association between hMLH1 hypermethylation and JC virus (JCV) infection in human colorectal cancer (CRC). Clinical Epigenetics 2011, 2:1-5.
9. Moody C.A., Laimins L.A. Human papillomavirus oncoproteins: pathways to transformation. Nature Reviews Cancer 2010, 10:550-560.
10. zur Hausen H. Viruses in human cancers. European Journal of Cancer 1999, 35:1878-1885.
11. Pisani P., Parkin D.M., Munoz N., Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiology, Biomarkers and Prevention: A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997, 6:387-400.
12. Zhang J., Markus J., Bies J., Paul T., Wolff L. Three murine leukemia virus integration regions within 100 kilobases upstream of c-myb are proximal to the 5' regulatory region of the gene through DNA looping. Journal of Virology 2012, 86:10524-10532.
13. Buhler S., Bartenschlager R. New targets for antiviral therapy of chronic hepatitis C. Liver International: Official Journal of the International Association for the Study of the Liver 2012, 32(Suppl. 1):9-16.
14. Vendramini-Costa D.B., Carvalho J.E. Molecular link mechanisms between inflammation and cancer. Current Pharmaceutical Design 2012, 18:3831-3852.
15. Aoshiba K., Tsuji T., Yamaguchi K., Itoh M., Nakamura H. The danger signal plus DNA damage 2-hit hypothesis for chronic inflammation in COPD. European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 2013, 42(6):1689-1695.
16. Schuessler H., Jung E. Protein-DNA-crosslinks induced by primary and secondary radicals. Free Radical Research Communications 1989, 6:161.
17. Fredriksson M.I. Effect of priming in subpopulations of peripheral neutrophils from patients with chronic periodontitis. Journal of Periodontology 2012, 83:1192-1199.
18. Perletti G., Montanari E., Vral A., Gazzano G., Marras E., Mione S., Magri V. Inflammation, prostatitis, proliferative inflammatory atrophy: 'fertile ground' for prostate cancer development?. Molecular Medicine Reports 2010, 3:3-12.
19. Denny L.A., Franceschi S., de Sanjose S., Heard I., Moscicki A.B., Palefsky J. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 2012, 30(Suppl. 5):F168-F174.
20. Zur Hausen H. Papillomavirus in anogenital cancer: the dilemma of epidemiologic approaches. Journal of the National Cancer Institute 1989, 81:1680-1682.
21. Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., Sibley R.K. Helicobacter pylori infection and the risk of gastric carcinoma. New England Journal of Medicine 1991, 325:1127-1131.
22. Wotherspoon A.C., Ortiz-Hidalgo C., Falzon M.R., Isaacson P.G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991, 338:1175-1176.
23. Herrera L.A., Benitez-Bribiesca L., Mohar A., Ostrosky-Wegman P. Role of infectious diseases in human carcinogenesis. Environmental and Molecular Mutagenesis 2005, 45:284-303.
24. Sobala G.M., Crabtree J.E., Dixon M.F., Schorah C.J., Taylor J.D., Rathbone B.J., Heatley R.V., Axon A.T. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 1991, 32:1415-1418.
25. Fock K.M., Ang T.L. Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. Journal of Gastroenterology and Hepatology 2010, 25:479-486.
26. Burnett-Hartman A.N., Newcomb P.A., Potter J.D. Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiology, Biomarkers and Prevention: A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008, 17:2970-2979.
27. Kikuchi S. Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2002, 5:6-15.
28. Forman D., Newell D.G., Fullerton F., Yarnell J.W., Stacey A.R., Wald N., Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991, 302:1302-1305.
29. Nomura A., Stemmermann G.N., Chyou P.H., Kato I., Perez-Perez G.I., Blaser M.J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. New England Journal of Medicine 1991, 325:1132-1136.
30. Watanabe Y., Kurata J.H., Mizuno S., Mukai M., Inokuchi H., Miki K., Ozasa K., Kawai K. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Digestive Diseases and Sciences 1997, 42:1383-1387.
31. Webb P.M., Yu M.C., Forman D., Henderson B.E., Newell D.G., Yuan J.M., Gao Y.T., Ross R.K. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. International Journal of Cancer 1996, 67:603-607.
32. Lin J.T., Wang L.Y., Wang J.T., Wang T.H., Yang C.S., Chen C.J. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Research 1995, 15:603-606.
33. Zumkeller N., Brenner H., Zwahlen M., Rothenbacher D. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 2006, 11:75-80.
34. Shmuely H., Passaro D., Figer A., Niv Y., Pitlik S., Samra Z., Koren R., Yahav J. Relationship between Helicobacter pylori CagA status and colorectal cancer. American Journal of Gastroenterology 2001, 96:3406-3410.
35. Chen T.S., Chang F.Y., Chen P.C., Huang T.W., Ou J.T., Tsai M.H., Wu M.S., Lin J.T. Simplified 13C-urea breath test with a new infrared spectrometer for diagnosis of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2003, 18:1237-1243.
36. Fujimori S., Kishida T., Kobayashi T., Sekita Y., Seo T., Nagata K., Tatsuguchi A., Gudis K., Yokoi K., Tanaka N., Yamashita K., Tajiri T., Ohaki Y., Sakamoto C. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. Journal of Gastroenterology 2005, 40:887-893.
37. Liou J.M., Lin J.W., Huang S.P., Lin J.T., Wu M.S. Helicobacter pylori infection is not associated with increased risk of colorectal polyps in Taiwanese. International Journal of Cancer 2006, 119:1999-2000.
38. Monstein H.J., Olsson C., Nilsson I., Grahn N., Benoni C., Ahrne S. Multiple displacement amplification of DNA from human colon and rectum biopsies: bacterial profiling and identification of Helicobacter pylori-DNA by means of 16S rDNA-based TTGE and pyrosequencing analysis. Journal of Microbiological Methods 2005, 63:239-247.
39. Jones M., Helliwell P., Pritchard C., Tharakan J., Mathew J. Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship?. World Journal of Surgical Oncology 2007, 5:51.
40. Bulajic M., Stimec B., Jesenofsky R., Kecmanovic D., Ceranic M., Kostic N., Schneider-Brachert W., Lowenfels A., Maisonneuve P., Lohr J.M. Helicobacter pylori in colorectal carcinoma tissue. Cancer Epidemiology, Biomarkers and Prevention: A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007, 16:631-633.
41. Noble C.J. Carriage of group D streptococci in the human bowel. Journal of Clinical Pathology 1978, 31:1182-1186.
42. Kupferwasser I., Darius H., Muller A.M., Mohr-Kahaly S., Westermeier T., Oelert H., Erbel R., Meyer J. Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases. Heart 1998, 80:276-280.
43. Mc C.W., Mason J.M. Enterococcal endocarditis associated with carcinoma of the sigmoid; report of a case. Journal of the Medical Association of the State of Alabama 1951, 21:162-166.
44. Gold J.S., Bayar S., Salem R.R. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Archives of Surgery 2004, 139:760-765.
45. Leport C., Bure A., Leport J., Vilde J.L. Incidence of colonic lesions in Streptococcus bovis and enterococcal endocarditis. Lancet 1987, 1:748.
46. Pergola V., Di Salvo G., Habib G., Avierinos J.F., Philip E., Vailloud J.M., Thuny F., Casalta J.P., Ambrosi P., Lambert M., Riberi A., Ferracci A., Mesana T., Metras D., Harle J.R., Weiller P.J., Raoult D., Luccioni R. Comparison of clinical and echocardiographic characteristics of Streptococcus bovis endocarditis with that caused by other pathogens. American Journal of Cardiology 2001, 88:871-875.
47. Tjalsma H., Scholler-Guinard M., Lasonder E., Ruers T.J., Willems H.L., Swinkels D.W. Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. International Journal of Cancer 2006, 119:2127-2135.
48. Welton J.C., Marr J.S., Friedman S.M. Association between hepatobiliary cancer and typhoid carrier state. Lancet 1979, 1:791-794.
49. Caygill C.P., Braddick M., Hill M.J., Knowles R.L., Sharp J.C. The association between typhoid carriage, typhoid infection and subsequent cancer at a number of sites. European Journal of Cancer Prevention 1995, 4:187-193.
50. Tewari M., Mishra R.R., Shukla H.S. Salmonella typhi and gallbladder cancer: report from an endemic region. Hepatobiliary and Pancreatic Diseases International: HBPD INT 2010, 9:524-530.
51. Gillen C.D., Coddington R., Monteith P.G., Taylor R.H. Extraintestinal lymphoma in association with Whipple's disease. Gut 1993, 34:1627-1629.
52. Robinson D.C., Adriaans B., Hay R.J., Yesudian P. The clinical and epidemiologic features of tropical ulcer (tropical phagedenic ulcer). International Journal of Dermatology 1988, 27:49-53.
53. Isaacson P.G. Gastric lymphoma and Helicobacter pylori. New England Journal of Medicine 1994, 330:1310-1311.
54. Peterson M.C. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. New England Journal of Medicine 2004, 350:1685-1686. author reply 1685-1686.
55. Al-Saleem T., Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood 2005, 105:2274-2280.
56. Trotman B.W., Pavlick A.C., Igwegbe I.C., Goldstein M.M. Immunoproliferative small intestinal disease: case report and literature review. Journal of the Association for Academic Minority Physicians: The Official Publication of the Association for Academic Minority Physicians 1999, 10:88-93.
57. Kawai K., Kuwahara K., Oizumi N., Kitagaki H., Fujisawa S. Effects of carteolol hydrochloride on the in vitro production of LPS-induced proinflammatory cytokines by murine macrophage. Journal of Ocular Pharmacology and Therapeutics: The Official Journal of the Association for Ocular Pharmacology and Therapeutics 2004, 20:237-245.
58. Shacter E., Weitzman S.A. Chronic inflammation and cancer. Oncology (Williston Park) 2002, 16:217-226. 229; discussion 230-212.
59. Cajelli E., Ferraris A., Brambilla G. Mutagenicity of 4-hydroxynonenal in V79 Chinese hamster cells. Mutation Research 1987, 190:169-171.
60. Shah A.A., Byrne M.F., Cullen L., Walsh T., Fitzgerald D.J., Murray F.E. Effect of H. pylori infection on the expression of cyclooxygenase-2 in human gastric mucosa. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2003, 68:1-8.
61. Martin O.A., Redon C.E., Nakamura A.J., Dickey J.S., Georgakilas A.G., Bonner W.M. Systemic DNA damage related to cancer. Cancer Research 2011, 71:3437-3441.
62. Mothersill C., Seymour C. Radiation-induced bystander effects: past history and future directions. Radiation Research 2001, 155:759-767.
63. Delchier J.C., Lamarque D., Levy M., Tkoub E.M., Copie-Bergman C., Deforges L., Chaumette M.T., Haioun C. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type. American Journal of Gastroenterology 2001, 96:2324-2328.
64. Fischbach W., Tacke W., Greiner A., Konrad H., Muller H. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet 1997, 349:31-32.
65. Weber D.M., Dimopoulos M.A., Anandu D.P., Pugh W.C., Steinbach G. Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori. Gastroenterology 1994, 107:1835-1838.
66. Hasselbalch H.C. Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?. Leukemia Research 2013, 37:214-220.
67. Westbrook A.M., Wei B., Braun J., Schiestl R.H. Intestinal inflammation induces genotoxicity to extraintestinal tissues and cell types in mice. International Journal of Cancer 2011, 129:1815-1825.
68. Georgakilas A.G. Oxidative stress, DNA damage and repair in carcinogenesis: have we established a connection?. Cancer Letters 2012, 327:3-4.
69. Handa O., Naito Y., Yoshikawa T. Redox biology and gastric carcinogenesis: the role of Helicobacter pylori. Redox Report: Communications in Free Radical Research 2011, 16:1-7.
70. Prise K.M., O'Sullivan J.M. Radiation-induced bystander signalling in cancer therapy. Nature Reviews Cancer 2009, 9:351-360.
71. Lara-Tejero M., Galan J.E. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000, 290:354-357.
72. Rolig A.S., Carter J.E., Ottemann K.M. Bacterial chemotaxis modulates host cell apoptosis to establish a T-helper cell, type 17 (Th17)-dominant immune response in Helicobacter pylori infection. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:19749-19754.
73. Hiratsuka S. Vasculogenesis, angiogenesis and special features of tumor blood vessels. Frontiers in Bioscience: A Journal and Virtual Library 2011, 16:1413-1427.
74. Tugues S., Koch S., Gualandi L., Li X., Claesson-Welsh L. Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer. Molecular Aspects of Medicine 2011, 32:88-111.
75. Cerimele F., Brown L.F., Bravo F., Ihler G.M., Kouadio P., Arbiser J.L. Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor. American Journal of Pathology 2003, 163:1321-1327.
76. Maeno N., Oda H., Yoshiie K., Wahid M.R., Fujimura T., Matayoshi S. Live Bartonella henselae enhances endothelial cell proliferation without direct contact. Microbial Pathogenesis 1999, 27:419-427.
77. Martin C., Thevenot G., Danel S., Chapron J., Tazi A., Macey J., Dusser D.J., Fajac I., Burgel P.R. Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo. European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 2011, 38:939-946.
78. Takayama S., Takahashi H., Matsuo Y., Okada Y., Takeyama H. Effect of Helicobacter bilis infection on human bile duct cancer cells. Digestive Diseases and Sciences 2010, 55:1905-1910.
79. Kitadai Y., Sasaki A., Ito M., Tanaka S., Oue N., Yasui W., Aihara M., Imagawa K., Haruma K., Chayama K. Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochemical and Biophysical Research Communications 2003, 311:809-814.
80. Pousa I.D., Gisbert J.P. Gastric angiogenesis and Helicobacter pylori infection. Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva 2006, 98:527-541.
81. Coschi C.H., Dick F.A. Chromosome instability and deregulated proliferation: an unavoidable duo. Cellular and Molecular Life Sciences: CMLS 2012, 69:2009-2024.
82. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nature Reviews Cancer 2009, 9:153-166.
83. Lax A.J. Opinion: bacterial toxins and cancer-a case to answer?. Nature Reviews Microbiology 2005, 3:343-349.
84. Patyar S., Joshi R., Byrav D.S., Prakash A., Medhi B., Das B.K. Bacteria in cancer therapy: a novel experimental strategy. Journal of Biomedical Science 2010, 17:21.
85. Oswald E., Sugai M., Labigne A., Wu H.C., Fiorentini C., Boquet P., O'Brien A.D. Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibers. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:3814-3818.
86. Thomas W., Pullinger G.D., Lax A.J., Rozengurt E. Escherichia coli cytotoxic necrotizing factor and Pasteurella multocida toxin induce focal adhesion kinase autophosphorylation and Src association. Infection and Immunity 2001, 69:5931-5935.
87. Sierra J.C., Hobbs S.S., Chaturvedi R., Yan F., Wilson K.T., Peek R.M., Polk D.B. Induction of COX-2 expression by Helicobacter pylori is mediated by activation of epidermal growth factor receptor in gastric epithelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 2013, 305(2):G196-G203.
88. Gupta R.A., DuBois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Review Cancer 2001, 1:11-21.
89. Mulvey M.A., Schilling J.D., Hultgren S.J. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infection and Immunity 2001, 69:4572-4579.
90. Fiorentini C., Matarrese P., Straface E., Falzano L., Fabbri A., Donelli G., Cossarizza A., Boquet P., Malorni W. Toxin-induced activation of Rho GTP-binding protein increases Bcl-2 expression and influences mitochondrial homeostasis. Experimental Cell Research 1998, 242:341-350.
91. Rippere-Lampe K.E., Lang M., Cari H., Olson M., Lockman H., O'Brien A.D. Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infection and Immunity 2001, 69:6515-6519.
92. Hemrajani C., Berger C.N., Robinson K.S., Marches O., Mousnier A., Frankel G. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:3129-3134.
93. Nougayrede J.P., Foster G.H., Donnenberg M.S. Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2. Cellular Microbiology 2007, 9:680-693.
94. Papatheodorou P., Domanska G., Oxle M., Mathieu J., Selchow O., Kenny B., Rassow J. The enteropathogenic Escherichia coli (EPEC) map effector is imported into the mitochondrial matrix by the TOM/Hsp70 system and alters organelle morphology. Cellular Microbiology 2006, 8:677-689.
95. Blasche S., Mortl M., Steuber H., Siszler G., Nisa S., Schwarz F., Lavrik I., Gronewold T.M., Maskos K., Donnenberg M.S., Ullmann D., Uetz P., Kogl M. The E. coli effector protein NleF is a caspase inhibitor. PLoS ONE 2013, 8:e58937.
96. Pham T.H., Gao X., Tsai K., Olsen R., Wan F., Hardwidge P.R. Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2. Infection and Immunity 2012, 80:2133-2140.
97. Zhao S., Zhou Y., Wang C., Yang Y., Wu X., Wei Y., Zhu L., Zhao W., Zhang Q., Wan C. The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7. PLoS ONE 2013, 8:e55164.
98. Raymond B., Crepin V.F., Collins J.W., Frankel G. The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-κB-dependent manner. Cell Microbiology 2011, 13:1881-1893.
99. Behar S.M., Martin C.J., Booty M.G., Nishimura T., Zhao X., Gan H.X., Divangahi M., Remold H.G. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunology 2011, 4:279-287.
100. Finlay B.B., McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 2006, 124:767-782.
101. Bolvin A., Mesrobeanu I., Mesrobeanu L. Preparation of the specific polysaccharides of bacteria. Comptes rendus des seances de la socicete de biologie et des ses filiales 1933, 113:490-504.
102. Netea M.G., van Deuren M., Kullberg B.J., Cavaillon J.M., Van der Meer J.W. Does the shape of lipid A determine the interaction of LPS with toll-like receptors?. Trends in Immunology 2002, 23:135-139.
103. Rietschel E.T., Wollenweber H.W., Zahringer U., Luderitz O. Lipid A, the lipid component of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Klinische Wochenschrift 1982, 60:705-709.
104. Gaekwad J., Zhang Y., Zhang W., Reeves J., Wolfert M.A., Boons G.J. Differential induction of innate immune responses by synthetic lipid a derivatives. Journal of Biological Chemistry 2010, 285:29375-29386.
105. Gibbs R.J., Stewart J., Poxton I.R. The distribution of, and antibody response to, the core lipopolysaccharide region of Escherichia coli isolated from the faeces of healthy humans and cattle. Journal of Medical Microbiology 2004, 53:959-964.
106. Matsuura M. Structural modifications of bacterial lipopolysaccharide that facilitate gram-negative bacteria evasion of host innate immunity. Frontiers in Immunology 2013, 4:109.
107. Phillips N.J., Schilling B., McLendon M.K., Apicella M.A., Gibson B.W. Novel modification of lipid A of Francisella tularensis. Infection and Immunity 2004, 72:5340-5348.
108. Kawahara K., Tsukano H., Watanabe H., Lindner B., Matsuura M. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infection and Immunity 2002, 70:4092-4098.
109. Kusumoto S., Fukase K., Fukase Y., Kataoka M., Yoshizaki H., Sato K., Oikawa M., Suda Y. Structural basis for endotoxic and antagonistic activities: investigation with novel synthetic lipid A analogs. Journal of Endotoxin Research 2003, 9:361-366.
110. Kawasaki K., Ernst R.K., Miller S.I. 3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through toll-like receptor 4. Journal of Biological Chemistry 2004, 279:20044-20048.
111. Sukhithasri V., Nisha N., Biswas L., Anil Kumar V., Biswas R. Innate immune recognition of microbial cell wall components and microbial strategies to evade such recognitions. Microbiological Research 2013, 168:396-406.
112. Sarantis H., Grinstein S. Subversion of phagocytosis for pathogen survival. Cell Host and Microbe 2012, 12:419-431.
113. Nitsche-Schmitz D.P., Johansson H.M., Sastalla I., Reissmann S., Frick I.M., Chhatwal G.S. Group G streptococcal IgG binding molecules FOG and protein G have different impacts on opsonization by C1q. Journal of Biological Chemistry 2007, 282:17530-17536.
114. Schneider M.C., Prosser B.E., Caesar J.J., Kugelberg E., Li S., Zhang Q., Quoraishi S., Lovett J.E., Deane J.E., Sim R.B., Roversi P., Johnson S., Tang C.M., Lea S.M. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 2009, 458:890-893.
115. Sharp J.A., Echague C.G., Hair P.S., Ward M.D., Nyalwidhe J.O., Geoghegan J.A., Foster T.J., Cunnion K.M. Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic. PLoS ONE 2012, 7:e38407.
116. Andersson K., Carballeira N., Magnusson K.E., Persson C., Stendahl O., Wolf-Watz H., Fallman M. YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis. Molecular Microbiology 1996, 20:1057-1069.
117. Kaniga K., Uralil J., Bliska J.B., Galan J.E. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Molecular Microbiology 1996, 21:633-641.
118. Gebert B., Fischer W., Weiss E., Hoffmann R., Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003, 301:1099-1102.
119. Mistry D., Stockley R.A. IgA1 protease. International Journal of Biochemistry and Cell Biology 2006, 38:1244-1248.
120. Liu Y., Islam E.A., Jarvis G.A., Gray-Owen S.D., Russell M.W. Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-beta-dependent mechanisms. Mucosal Immunology 2012, 5:320-331.
121. Liu Y., Liu W., Russell M.W. Suppression of host adaptive immune responses by Neisseria gonorrhoeae: role of interleukin 10 and type 1 regulatory T cells. Mucosal Immunology 2013, 7:165-176.
122. Koturbash I., Thomas J.E., Kovalchuk O., Kovalchuk I. Heat-killed bacteria induce genome instability in mouse small intestine, liver and spleen tissues. Cell Cycle 2009, 8:1935-1939.
123. Kovalchuk I., Walz P., Thomas J., Kovalchuk O. The increased expression of proteins involved in proliferation, DNA repair and DNA methylation in spleen of mice exposed to E. coli O157:H7 lipopolysaccharide. Environmental and Molecular Mutagenesis 2013, 54:421-428.
124. Kovalchuk I., Walz P., Thomas J., Kovalchuk O. Genomic instability in liver cells caused by an LPS-induced bystander-like effect. PLoS ONE 2013, 8:e67342.
125. Olaya J., Neopikhanov V., Uribe A. Lipopolysaccharide of Escherichia coli, polyamines, and acetic acid stimulate cell proliferation in intestinal epithelial cells. In vitro Cellular and Developmental Biology Animal 1999, 35:43-48.
126. Luderitz O., Freudenberg M.A., Galanos C., Lehmann V., Rietschel Eth., Shaw D.H. Lipopolysaccharides of Gram-negative bacteria. Current Topics in Membrane Transport 1982, 17:79-134.
127. Yamada H., Arai T., Endo N., Yamashita K., Fukuda K., Sasada M., Uchiyama T. LPS-induced ROS generation and changes in glutathione level and their relation to the maturation of human monocyte-derived dendritic cells. Life Sciences 2006, 78:926-933.
128. Sanlioglu S., Williams C.M., Samavati L., Butler N.S., Wang G., McCray P.B., Ritchie T.C., Hunninghake G.W., Zandi E., Engelhardt J.F. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. Journal of Biological Chemistry 2001, 276:30188-30198.
129. Kudo H., Takahara T., Yata Y., Kawai K., Zhang W., Sugiyama T. Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. Journal of Hepatology 2009, 51:168-175.
130. Jackson G.D., Berkovic S.F., Tress B.M., Kalnins R.M., Fabinyi G.C., Bladin P.F. Hippocampal sclerosis can be reliably detected by magnetic resonance imaging. Neurology 1990, 40:1869-1875.
131. Reymond D., Johnson R.P., Karmali M.A., Petric M., Winkler M., Johnson S., Rahn K., Renwick S., Wilson J., Clarke R.C., Spika J. Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. Journal of Clinical Microbiology 1996, 34:2053-2057.
132. Hirschfeld M., Weis J.J., Toshchakov V., Salkowski C.A., Cody M.J., Ward D.C., Qureshi N., Michalek S.M., Vogel S.N. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infection and Immunity 2001, 69(3):1477-1482.
133. Schromm A.B., Brandenburg K., Loppnow H., Moran A.P., Koch M.H., Rietschel E.T., Seydel U. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. European Journal of Biochemistry/FEBS 2000, 267:2008-2013.
134. Yan J., Zhang M., Zhang J., Chen X., Zhang X. Helicobacter pylori infection promotes methylation of WWOX gene in human gastric cancer. Biochemical and Biophysical Research Communications 2011, 408:99-102.
135. Andersson J.O. Lateral gene transfer in eukaryotes. Cellular and Molecular Life Sciences: CMLS 2005, 62:1182-1197.
136. Gelvin S.B. Agrobacterium-mediated plant transformation: the biology behind the "gene-jockeying tool". Microbiology and Molecular Biology Reviews: MMBR 2003, 67:16-37. table of contents.
137. Werren J.H., Baldo L., Clark M.E. Wolbachia: master manipulators of invertebrate biology. Nature Reviews Microbiology 2008, 6:741-751.
138. Schroder G., Schuelein R., Quebatte M., Dehio C. Conjugative DNA transfer into human cells by the VirB/VirD4 type IV secretion system of the bacterial pathogen Bartonella henselae. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:14643-14648.
139. Koehler J.E., Sanchez M.A., Garrido C.S., Whitfeld M.J., Chen F.M., Berger T.G., Rodriguez-Barradas M.C., LeBoit P.E., Tappero J.W. Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. New England Journal of Medicine 1997, 337:1876-1883.
140. Riley D.R., Sieber K.B., Robinson K.M., White J.R., Ganesan A., Nourbakhsh S., Dunning Hotopp J.C. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Computational Biology 2013, 9:e1003107.
141. Arur S., Uche U.E., Rezaul K., Fong M., Scranton V., Cowan A.E., Mohler W., Han D.K. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Developmental Cell 2003, 4:587-598.
142. Nougayrede J.P., Donnenberg M.S. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cellular Microbiology 2004, 6:1097-1111.